Characterizing SARS-CoV-2-specific Immunity in Individuals Who Have Recovered From
How is the body's immune response to natural SARS-CoV-2 infection characterized?
Basic Study Information
Purpose:Location: University of Rochester Vaccines to Prevent HIV Infection CRS
The purpose of this study is to learn more about infection with and recovery from
the virus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Some
people know this virus by the name "coronavirus." It can cause the disease called
The information gained from the study will be used to help develop better tests for
SARS-CoV-2 infection and COVID-19 disease and may help in developing future vaccines
and treatments by allowing researchers to determine the difference between the body's
response to natural SARS-CoV-2 infection and immunization with a SARS-CoV-2 vaccine.
Inclusion Criteria: Age 18 or older / Have had a positive test for SARS-CoV-2 / Reports
resolution of COVID-19 within 1-8 weeks of enrollment OR, if asymptomatic infection,
reports positive SARS-CoV-2 test within 2-10 weeks of enrollment.
Study Reference #: 4970
Lead Researcher (Principal Investigator)
Study Contact InformationStudy Coordinator: CRS Leader
Phone: (585) 275-5871
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search